Cerebrolysin or Cerebrolysin‐like agents vs placebo
Total number of people with adverse events, · people with acute ischemic stroke
Cerebrolysin or Cerebrolysin‐like agents showed no clear difference in total number of people with adverse events, compared with placebo (low certainty).
1 finding from 1 review
- RR 1.03 [0.92, 1.14]4 studies · 1607 participantsLow